A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

COVID-19, is a disease resulting from the SARS-CoV-2 global pandemic. Due to the current global emergency and the length of time required to develop specific antiviral agent(s) and a vaccine for SARS-CoV-2, the world health organization (WHO) adopted the strategy of repurposing existing medications...

Descripción completa

Detalles Bibliográficos
Autores principales: Abo-zeid, Yasmin, Ismail, Nasser S.M., McLean, Gary R., Hamdy, Nadia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354764/
https://www.ncbi.nlm.nih.gov/pubmed/32668312
http://dx.doi.org/10.1016/j.ejps.2020.105465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354764/
https://www.ncbi.nlm.nih.gov/pubmed/32668312
http://dx.doi.org/10.1016/j.ejps.2020.105465

Ejemplares similares